Cdc2-DN-HA Citations (7)
Originally described in: Distinct roles for cyclin-dependent kinases in cell cycle control.van den Heuvel S, Harlow E Science 1993 Dec 24;262(5142):2050-4. PubMed Journal
Articles Citing Cdc2-DN-HA
| Articles |
|---|
CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.
Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B, Yang CC, Yang JY, Lin CY, Lai CC, Hung MC.
Nat Cell Biol. 2011 Jan . 13(1):87-94.
PubMed
Associated Plasmids |
| Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines. Chen CH, Liao CH, Chang YL, Guh JH, Pan SL, Teng CM. Cancer Lett. 2012 Feb 1;315(1):1-11. doi: 10.1016/j.canlet.2011.09.042. Epub 2011 Oct 8. PubMed |
| The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer. Al Sorkhy M, Ferraiuolo RM, Jalili E, Malysa A, Fratiloiu AR, Sloane BF, Porter LA. BMC Cancer. 2012 Jan 26;12:45. doi: 10.1186/1471-2407-12-45. PubMed |
| Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status. Pfister JA, D'Mello SR. J Biol Chem. 2016 Sep 23;291(39):20787-97. doi: 10.1074/jbc.M116.723015. Epub 2016 Aug 10. PubMed |
| Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Polanco MJ, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, Miranda HC, Lievens PM, Espinoza S, Jochum T, Rocchi A, Grunseich C, Gainetdinov RR, Cato AC, Lieberman AP, La Spada AR, Sambataro F, Fischbeck KH, Gozes I, Pennuto M. Sci Transl Med. 2016 Dec 21;8(370):370ra181. doi: 10.1126/scitranslmed.aaf9526. PubMed |
| The cyclin-like protein, SPY1, regulates the ERalpha and ERK1/2 pathways promoting tamoxifen resistance. Ferraiuolo RM, Tubman J, Sinha I, Hamm C, Porter LA. Oncotarget. 2017 Apr 4;8(14):23337-23352. doi: 10.18632/oncotarget.15578. PubMed |
| ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer. Tang Z, Pilie PG, Geng C, Manyam GC, Yang G, Park S, Wang D, Peng S, Wu C, Peng G, Yap TA, Corn PG, Broom BM, Thompson TC. Clin Cancer Res. 2021 Sep 1;27(17):4898-4909. doi: 10.1158/1078-0432.CCR-21-1010. Epub 2021 Jun 24. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.